NEW YORK, November 28, 2017 /PRNewswire/ --
In keeping with the commitment to dynamically provide members with timely information WallStEquities.com has issued free tailored Stock Review on ACHC, DVA, HLS, and MD which is a click away at http://www.wallstequities.com/registration. Pre-market today, WallStEquities.com scans Acadia Healthcare Co. Inc. (NASDAQ: ACHC), DaVita Inc. (NYSE: DVA), HealthSouth Corp. (NYSE: HLS), and MEDNAX Inc. (NYSE: MD). Specialized Health Services companies produce and distribute varying paper products to customers and businesses of all shapes and sizes. On average, the dividend yields of these firms tend to be slightly above the market average. With Wall St. Equities' free research reports get an edge over stock markets, sign up now at:
http://www.wallstequities.com/registration
Acadia Healthcare
Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.'s shares gained 2.24%, closing Monday's trading session at $31.04. The stock recorded a trading volume of 1.11 million shares. The Company's shares are trading 19.30% below their 50-day moving average. Additionally, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, have a Relative Strength Index (RSI) of 41.11.
On November 03rd, 2017, research firm Credit Suisse initiated a 'Neutral' rating on the Company's stock. Our free and thorough report on ACHC awaits you at:
http://www.wallstequities.com/registration/?symbol=ACHC
DaVita
On Monday, shares in Denver, Colorado headquartered DaVita Inc. recorded a trading volume of 2.89 million shares, which was above their three months average volume of 2.19 million shares. The stock climbed 1.47%, ending the day at $57.99. The Company's shares have advanced 1.17% in the previous three months. The stock is trading lightly below its 50-day moving average by 0.15%. Furthermore, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have an RSI of 54.08.
On November 03rd, 2017, DaVita Kidney Care, a division of DaVita, announced its strong support for the Dialysis PATIENTS Demonstration Act ("PATIENTS Act") (H.R. 4143 / S. 2065). Integrated care programs, such as the PATIENTS Act, offer patients added benefits like access to a care coordination team and medically necessary transportation. This legislation combines precedents established from Accountable Care Organizations and Medicare Advantage to enhance the integrated care model for dialysis patients.
On November 08th, 2017, research firm RBC Capital Markets reiterated its 'Sector Perform' rating on the Company's stock with a decrease of the target price from $64 a share to $60 a share. DVA complimentary research coverage a few simple steps away at:
http://www.wallstequities.com/registration/?symbol=DVA
HealthSouth
Birmingham, Alabama headquartered HealthSouth Corp.'s stock finished the day 1.99% lower at $48.18 with a total trading volume of 698,543 shares. The Company's shares have advanced 8.81% in the last one month, 8.64% in the previous three months, and 16.83% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 3.77% and 6.81%, respectively. Additionally, shares of HealthSouth, which provides facility-based and home-based post-acute healthcare services in the US, have an RSI of 52.46. Register for your free research report on HLS at:
http://www.wallstequities.com/registration/?symbol=HLS
MEDNAX
Shares in Sunrise, Florida headquartered MEDNAX Inc. ended yesterday's session 1.57% lower at $48.33. The stock recorded a trading volume of 1.29 million shares. The Company's shares have advanced 11.13% in the last one month and 9.47% over the previous three months. The stock is trading 9.44% above its 50-day moving average. Moreover, shares of MEDNAX, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 58.52.
On November 22nd, 2017, MEDNAX announced that it will present at the Bank of America Merrill Lynch 2017 Leveraged Finance Conference on November 29th, 2017, at 2:10 p.m. ET in Boca Raton. The Company will also present at the Citi 2017 Global Healthcare Conference on December 06th, 2017, at 2:10 p.m. ET in New York. A live audio webcast of both presentations will be available on the Company's investor website. Wall St. Equities' downloadable research report on MD available at:
http://www.wallstequities.com/registration/?symbol=MD
--
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
https://wallstequities.com/legal-disclaimer/
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +21-32-044-483 Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Wall St. Equities
Advertisement
In keeping with the commitment to dynamically provide members with timely information WallStEquities.com has issued free tailored Stock Review on ACHC, DVA, HLS, and MD which is a click away at http://www.wallstequities.com/registration. Pre-market today, WallStEquities.com scans Acadia Healthcare Co. Inc. (NASDAQ: ACHC), DaVita Inc. (NYSE: DVA), HealthSouth Corp. (NYSE: HLS), and MEDNAX Inc. (NYSE: MD). Specialized Health Services companies produce and distribute varying paper products to customers and businesses of all shapes and sizes. On average, the dividend yields of these firms tend to be slightly above the market average. With Wall St. Equities' free research reports get an edge over stock markets, sign up now at:
Advertisement
http://www.wallstequities.com/registration
Acadia Healthcare
Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.'s shares gained 2.24%, closing Monday's trading session at $31.04. The stock recorded a trading volume of 1.11 million shares. The Company's shares are trading 19.30% below their 50-day moving average. Additionally, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, have a Relative Strength Index (RSI) of 41.11.
On November 03rd, 2017, research firm Credit Suisse initiated a 'Neutral' rating on the Company's stock. Our free and thorough report on ACHC awaits you at:
http://www.wallstequities.com/registration/?symbol=ACHC
DaVita
On Monday, shares in Denver, Colorado headquartered DaVita Inc. recorded a trading volume of 2.89 million shares, which was above their three months average volume of 2.19 million shares. The stock climbed 1.47%, ending the day at $57.99. The Company's shares have advanced 1.17% in the previous three months. The stock is trading lightly below its 50-day moving average by 0.15%. Furthermore, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have an RSI of 54.08.
On November 03rd, 2017, DaVita Kidney Care, a division of DaVita, announced its strong support for the Dialysis PATIENTS Demonstration Act ("PATIENTS Act") (H.R. 4143 / S. 2065). Integrated care programs, such as the PATIENTS Act, offer patients added benefits like access to a care coordination team and medically necessary transportation. This legislation combines precedents established from Accountable Care Organizations and Medicare Advantage to enhance the integrated care model for dialysis patients.
On November 08th, 2017, research firm RBC Capital Markets reiterated its 'Sector Perform' rating on the Company's stock with a decrease of the target price from $64 a share to $60 a share. DVA complimentary research coverage a few simple steps away at:
http://www.wallstequities.com/registration/?symbol=DVA
HealthSouth
Birmingham, Alabama headquartered HealthSouth Corp.'s stock finished the day 1.99% lower at $48.18 with a total trading volume of 698,543 shares. The Company's shares have advanced 8.81% in the last one month, 8.64% in the previous three months, and 16.83% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 3.77% and 6.81%, respectively. Additionally, shares of HealthSouth, which provides facility-based and home-based post-acute healthcare services in the US, have an RSI of 52.46. Register for your free research report on HLS at:
http://www.wallstequities.com/registration/?symbol=HLS
MEDNAX
Shares in Sunrise, Florida headquartered MEDNAX Inc. ended yesterday's session 1.57% lower at $48.33. The stock recorded a trading volume of 1.29 million shares. The Company's shares have advanced 11.13% in the last one month and 9.47% over the previous three months. The stock is trading 9.44% above its 50-day moving average. Moreover, shares of MEDNAX, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 58.52.
On November 22nd, 2017, MEDNAX announced that it will present at the Bank of America Merrill Lynch 2017 Leveraged Finance Conference on November 29th, 2017, at 2:10 p.m. ET in Boca Raton. The Company will also present at the Citi 2017 Global Healthcare Conference on December 06th, 2017, at 2:10 p.m. ET in New York. A live audio webcast of both presentations will be available on the Company's investor website. Wall St. Equities' downloadable research report on MD available at:
http://www.wallstequities.com/registration/?symbol=MD
--
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
https://wallstequities.com/legal-disclaimer/
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +21-32-044-483 Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Wall St. Equities
